Indian drugmaker Aurobindo Pharma (ARBN.NS) reported a 25.2% rise in quarterly profit on Wednesday, driven by steady domestic demand, especially for its anti-retroviral drugs used to treat HIV infections.
Here are more details:
($1 = 95.1175 Indian rupees)
